Aklimunnessa Khandoker, Mori Mitsuru, Khan M M H, Sakauchi Fumio, Kubo Tatsuhiko, Fujino Yoshihisa, Suzuki Sadao, Tokudome Shinkan, Tamakoshi Akiko, Motohashi Yutaka, Tsuji Ichiro, Nakamura Yosikazu, Iso Hiroyasu, Mikami Haruo, Inaba Yutaka, Hoshiyama Yoshiharu, Suzuki Hiroshi, Shimizu Hiroyuki, Toyoshima Hideaki, Wakai Kenji, Ito Yoshinori, Hashimoto Shuji, Kikuchi Shogo, Koizumi Akio, Kawamura Takashi, Watanabe Yoshiyuki, Miki Tsuneharu, Date Chigusa, Sakata Kiyomi, Nose Takayuki, Hayakawa Norihiko, Yoshimura Takesumi, Shibata Akira, Okamoto Naoyuki, Shino Hideo, Ohno Yoshiyuki, Kitagawa Tomoyuki, Kuroki Toshio, Tajima Kazuo
Department of Public Health, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Jpn J Clin Oncol. 2006 Aug;36(8):511-8. doi: 10.1093/jjco/hyl060. Epub 2006 Jul 14.
Various studies have revealed that cervical cancer (CC) screening significantly reduces both CC incidence and mortality in developed countries. Although Japan introduced a nationwide government funded annual CC screening for the women aged 30+ in 1982, the effectiveness of CC screening on CC mortality has not yet been evaluated by any prospective cohort study. Therefore, the present study evaluated the association of CC mortality with self-reported CC screening and some other factors by a nationwide cohort study.
Baseline survey of the Japan Collaborative Cohort Study for the enrollment of subjects was completed during 1988-90 and followed until 2003. This study only analyzed 63,541 women, aged 30-79 years, who were free from any cancer history at enrollment.
During the follow-up period, 38 CC deaths were identified. The mean age at mortality was 67.0 years, with a mortality rate of 4.2 per 100,000 person-years. Participation rate in CC screening was 46.9%. Age-adjusted Cox model indicated significantly lower CC mortality [hazard ratio (HR) = 0.30, 95% confidence interval (CI) = 0.12-0.74] due to CC screening. Protectiveness remained almost the same (HR = 0.30, 95% CI = 0.12-0.76) when adjusted for age, body mass index and number of deliveries. The results also revealed that CC screening could reduce at least 50% of CC deaths even after excluding the effect of possible self-selection bias.
CC screening in Japan may reduce CC mortality significantly for women aged 30-79 years. However, further studies with more CC deaths and increased statistical power are needed to validate the findings.
多项研究表明,在发达国家,宫颈癌(CC)筛查可显著降低CC发病率和死亡率。尽管日本于1982年在全国范围内推行了由政府资助的针对30岁及以上女性的年度CC筛查,但尚未有前瞻性队列研究评估CC筛查对CC死亡率的有效性。因此,本研究通过全国性队列研究评估了CC死亡率与自我报告的CC筛查及其他一些因素之间的关联。
日本合作队列研究的基线调查于1988 - 1990年完成,用于招募研究对象,并随访至2003年。本研究仅分析了63541名年龄在30 - 79岁之间、入组时无任何癌症病史的女性。
在随访期间,共确定了38例CC死亡病例。死亡时的平均年龄为67.0岁,死亡率为每10万人年4.2例。CC筛查的参与率为46.9%。年龄调整后的Cox模型表明,CC筛查导致CC死亡率显著降低[风险比(HR)= 0.30,95%置信区间(CI)= 0.12 - 0.74]。在对年龄、体重指数和分娩次数进行调整后,保护作用几乎保持不变(HR = 0.30,95% CI = 0.12 - 0.76)。结果还显示,即使排除可能的自我选择偏倚的影响,CC筛查仍可至少降低50%的CC死亡。
日本的CC筛查可能会显著降低30 - 79岁女性的CC死亡率。然而,需要更多的CC死亡病例和更强的统计效力进行进一步研究以验证这些发现。